Susan D. Spencer
Genesys (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Organic Electronics and Photovoltaics, Click Chemistry and Applications, Electron Spin Resonance Studies
Most-Cited Works
- → Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate(2008)1,659 cited
- → Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index(2008)1,323 cited
- → Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand(1994)1,309 cited
- → Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons(1994)1,060 cited
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor(1998)366 cited
- → Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer(2010)290 cited
- → Protein Tyrosine Phosphatase-PEST Regulates Focal Adhesion Disassembly, Migration, and Cytokinesis in Fibroblasts(1999)279 cited
- → Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase(2000)267 cited
- → Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection(2009)248 cited